Significant Increase in Hospital Clients
Beyond Air increased its total number of hospital clients by over 60% in the quarter ended September 30, 2024, indicating successful marketing and customer education strategies.
Strategic Partnerships and Financial Agreements
Announced partnerships with Healthcare Links, TrillaMed, and Business Asia Consultants for distribution to various regions. Completed a $20.6 million private placement equity offering and reached agreements to extend cash runway.
Revenue Growth
Revenue for the second fiscal quarter of 2025 was $0.8 million compared to $0.2 million in the same quarter of 2024, indicating a significant increase.
Reduced Operating Expenses
Research and development expenses reduced from $7.1 million to $4.6 million, and SG&A expenses reduced from $10.2 million to $7.2 million year-over-year.
Positive Outlook on Regulatory Approvals and Product Development
PMA supplement for LungFit PH expansion is under review by the FDA, and CE Mark approval in the EU is anticipated before the end of the calendar year.